Targeted Antibiotic Delivery:
The Platform of Choice for Surgical Antibiotic Prophylaxis
Rethinking Surgical Antibiotic Prophylaxis
The current standard of care for surgical antibiotic prophylaxis relies on systemic delivery, leading to unpredictable efficacy at the target site, unnecessary antibiotic exposure and potential harm to the microbiome.
Binary Pharmaceuticals offers a targeted solution: intradermal delivery. By delivering antibiotics directly to the surgical site, we minimize systemic effects while ensuring optimal concentrations where they’re needed most.
Timing and Concentration are Critical
Our platform ensures precision of dosing of antibiotics at the surgical site, optimizing effectiveness and reducing the risk of complications.
Discover the benefits
Binary Pharmaceuticals: A Public Benefit Corporation
Our mission is to transform global antibiotic delivery. We are committed to developing innovative, accessible, and affordable solutions that minimize harm and maximize patient outcomes. By challenging the status quo during the age of antimicrobial resistance, we strive to create a future where antibiotics are used more effectively and responsibly.
Our Team
The Executive Board
Angela Sutterer, PhD
Angela Sutterer is a pharmaceutical development leader with proven experience in NDA, ANDA and OTC product development and manufacturing.
Full Bio
Dowling B. Stough M.D.FAAD
Dr. Stough is the founding dermatologist of The Dermatology Clinic, P.A. and Medical Director of Burke Pharmaceutical Research.
Full Bio
Pat Quinlan M.D.
CEO, Hippo Technologies Inc
Dr. Quinlan has deep experience in all major facets of health care, including direct medical care, governance, medical insurance, and medical & administrative management of fully integrated delivery systems.
Full Bio
Burke Stough, Esq
D. Burke Stough is a seasoned legal and business professional with a strong foundation in law, accounting, and compliance. He brings a multidimensional skill set that supports mission-driven organizations achieve long-lasting impacts.
Full Bio
The Scientific Board
Ryan Dare, M.D.
Ryan K Dare, MD is Assistant Professor in the Division of Infectious Diseases at UAMS (University Hospital) in Little Rock, Arkansas. His interest in infectious disease was initially kindled by his research work with the CDC.
Full Bio
John Zitelli, M.D.
(Will have to get his bio and photo)
Full Bio
Karl Wagenhauser, M.D.
Dr Wagenhauser, is a board certified Emergency Medicine Specialist with 29 years of experience as a medical professional. He has held various medical positions including Staff Physician, Chief Medical Officer, Medical Director and Assistant Medical Director.
Full Bio
What is Intradermal Delivery?
This delivery method allows novel targeted delivery of antibiotic at micro-concentrations compared to the systemic standard of care.
Read more
Binary Pharmaceuticals develops accessible and affordable antibiotic delivery platforms in the interest of public health.